Reference priceEUR €4.84Original source price: INR 440.00. Converted estimates are available by currency selection.
| Brand | Mavyret |
|---|---|
| Manufacturer | AbbVie Inc |
| Prescription required | Yes |
Mavyret 50mg/20mg oral pellets,1 x 28packet (glecaprevir/pibrentasvir)
glecaprevir/pibrentasvir
Description
Mavyret 50mg/20mg oral pellets,1 x 28packet(/) (glecaprevir/pibrentasvir) is a medicine catalog record in the MediPriceHub database. Active ingredient: glecaprevir/pibrentasvir. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: AbbVie Inc. Therapeutic category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis C drugs. Pack information: 50 / 20 28. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Glecaprevir with pibrentasvir is a direct-acting antiviral combination used to treat chronic hepatitis C virus infection across multiple genotypes, with regimen details depending on cirrhosis status, prior treatment, renal function, and the approved local label.How to Use
Use glecaprevir/pibrentasvir under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: glecaprevir/pibrentasvir. Pack size: 50 / 20 28. Pack unit: box. Manufacturer: AbbVie Inc. Origin country: United States. Source category: Medicine Library > Liver and Gallbladder Diseases > Hepatitis C drugs. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.Diese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.